Theravance Biopharma, Inc. (TBPH)
17.05
+0.02
(+0.12%)
USD |
NASDAQ |
Aug 26, 10:35
Theravance Biopharma Total Return Level : 17.03 for Aug. 25, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 25, 2026 | 17.03 |
| August 24, 2026 | 17.01 |
| August 21, 2026 | 17.01 |
| August 20, 2026 | 16.95 |
| August 19, 2026 | 16.99 |
| August 18, 2026 | 16.95 |
| August 17, 2026 | 16.92 |
| August 14, 2026 | 16.97 |
| August 13, 2026 | 16.92 |
| August 12, 2026 | 16.92 |
| August 11, 2026 | 16.92 |
| August 10, 2026 | 16.91 |
| August 07, 2026 | 16.93 |
| August 06, 2026 | 16.92 |
| August 05, 2026 | 16.90 |
| August 04, 2026 | 16.88 |
| August 03, 2026 | 16.87 |
| July 31, 2026 | 16.86 |
| July 30, 2026 | 16.85 |
| July 29, 2026 | 16.85 |
| July 28, 2026 | 16.89 |
| July 27, 2026 | 16.86 |
| July 24, 2026 | 16.86 |
| July 23, 2026 | 16.86 |
| July 22, 2026 | 16.81 |
| Date | Value |
|---|---|
| July 21, 2026 | 16.84 |
| July 20, 2026 | 16.81 |
| July 17, 2026 | 16.93 |
| July 16, 2026 | 16.97 |
| July 15, 2026 | 16.93 |
| July 14, 2026 | 16.92 |
| July 13, 2026 | 16.90 |
| July 10, 2026 | 16.93 |
| July 09, 2026 | 16.98 |
| July 08, 2026 | 17.00 |
| July 07, 2026 | 17.01 |
| July 06, 2026 | 17.00 |
| July 02, 2026 | 16.93 |
| July 01, 2026 | 16.98 |
| June 30, 2026 | 17.00 |
| June 29, 2026 | 17.06 |
| June 26, 2026 | 17.63 |
| June 25, 2026 | 17.39 |
| June 24, 2026 | 17.27 |
| June 23, 2026 | 16.97 |
| June 22, 2026 | 16.56 |
| June 18, 2026 | 16.58 |
| June 17, 2026 | 16.71 |
| June 16, 2026 | 16.69 |
| June 15, 2026 | 16.32 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Zymeworks, Inc. | 27.47 |
| Viatris, Inc. | 20.93 |
| Ocular Therapeutix, Inc. | 10.88 |
| ANI Pharmaceuticals, Inc. | 75.65 |
| Corcept Therapeutics, Inc. | 123.57 |